Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging

Launched by FATEBENEFRATELLI HOSPITAL · Oct 4, 2021

Keywords

ClinConnect Summary

The Stress Echo 2030 trial is studying a new way to use heart imaging, called the ABCDE-(FGLPR) protocol, to better understand and treat various heart conditions like coronary artery disease, heart failure, and valvular heart disease. This trial aims to include over 10,000 patients from different countries over the next five years. If you have known or suspected coronary artery disease, hypertrophic cardiomyopathy, or have had repairs for Tetralogy of Fallot, you might be eligible to participate.

Participants in this study can expect to undergo a special type of heart test called a stress echocardiogram, which helps doctors see how well the heart is functioning under stress. The goal is to gather important information that can improve heart care for everyone, especially during times like the COVID-19 pandemic. The study is currently recruiting patients of all genders and ages, so if you think you might qualify, it could be a great opportunity to contribute to heart health research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Known or suspected coronary artery disease Hypertrofic cardiomiopathy Repaired Tetralogy of Fallot Primary valvular disease
• Exclusion Criteria:
• • -